Press release
Global Peptide Therapeutics Market Poised for Significant Growth with Rising Cancer Prevalence and Technological Advancements
Peptide Therapeutics Market
Click To get SAMPLE PDF (Including Full TOC, Graphs & Charts, Table & Figures)@ https://www.emergenresearch.com/request-sample/2736
Key Market Drivers
The surge in cancer cases worldwide is a significant factor driving the expansion of peptide therapeutics. According to the World Health Organization (WHO), cancer was responsible for around 10 million deaths in 2020, with leading causes including breast, lung, liver, and prostate cancers. Peptide-based therapies have shown great potential in revolutionizing cancer treatment due to their ability to target specific cancer cells while sparing healthy tissues. This precision has led to the development of innovative drugs like peptide drug conjugates (PDCs) and cell-penetrating peptides, which are further boosting market growth.
Advances in delivery systems, such as nanoparticles, liposomes, and micelles, are enhancing the effectiveness of peptide therapies by improving drug stability and reducing side effects. Collaborations between industry leaders, including partnerships leveraging artificial intelligence for drug discovery, are also contributing to the momentum in the peptide therapeutics space.
Innovative Peptide Segment Leads Market Growth
In 2022, the innovative peptide segment held the largest share of the global market. These peptides offer high purity and consistency, making them the preferred choice for pharmaceutical companies. Their ability to target specific diseases, such as diabetes, autoimmune disorders, and cancer, has fueled their widespread adoption. Drugs like semaglutide, which helps regulate blood sugar, and pegfilgrastim, used to mitigate chemotherapy side effects, exemplify the therapeutic power of peptides.
The generic peptide segment is expected to grow steadily as patents on innovative peptides expire, allowing more affordable versions to enter the market. This trend is making peptide therapies accessible to a broader population.
Request For An Discount@ https://www.emergenresearch.com/request-discount/2736
Cancer Remains a Major Application Area
Cancer treatment continues to be a dominant application for peptide therapeutics. The targeting of specific cancer cell receptors has made peptides an effective option for a wide range of cancers. With approximately 1.9 million new cancer cases in the U.S. in 2022 and the launch of novel treatments like Cybrexa Therapeutics' CBX-15, a breast cancer-targeting PDC, the segment is projected to see sustained growth.
Metabolic Disorders and Other Applications on the Rise
The prevalence of metabolic disorders, including diabetes and obesity, is also contributing to market expansion. With an aging population and lifestyle-related factors driving the rise in these conditions, peptide-based drugs are offering promising treatment options. According to the International Diabetes Federation, over 537 million people worldwide are living with diabetes, underscoring the need for effective therapies.
Parenteral Administration Dominates the Market
Peptide drugs administered parenterally (via injection) accounted for the largest market share in 2022. This method ensures rapid absorption and high bioavailability, crucial for treating acute conditions and delivering high-potency medications. The precision offered by this route of administration makes it a preferred option for healthcare providers.
In-House Manufacturing Gaining Traction
The in-house manufacturing of peptide therapeutics is expected to grow rapidly, as it allows companies to maintain control over their intellectual property and customize peptide production. This setup facilitates close collaboration between research and development teams and manufacturing units, accelerating the drug development process and ensuring high-quality output.
Peptide Therapeutics Top Companies and Competitive Landscape
The global peptide therapeutics market is fairly fragmented with many large and medium-sized players accounting for majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing more effective peptide therapeutics solutions.
Some major players included in the global peptide therapeutics market report are:
AstraZeneca
Amgen Inc.
GSK plc.
Pfizer Inc.
Sanofi
AbbVie Inc.
Bristol Myers Squibb Company
Eli Lilly and Company
Novartis AG
Baush Health companies Inc.
Interested in knowing more relevant information? Click here: https://www.emergenresearch.com/industry-report/peptide-therapeutics-market
Peptide Therapeutics Latest Industry Updates
On 22 June 2023, IRBM collaborated with Merck & Co. Inc. to continue their development in the peptide therapeutics area. The utilization of novel technologies, such as phage display peptide libraries and half-life extension strategies, has accelerated the development of peptide candidates with enhanced therapeutic potential. This collaboration has taken advantage of these novel technologies to develop peptide candidates that progress into the clinic.
On 31 May 2022, Sapience Therapeutics announced the development of peptide therapeutics to address difficult-to-treat cancers.ST101, a first-in-class antagonist evaluated in the Phase 2 portion of an ongoing Phase 1-2 clinical study in patients with advanced unresectable and metastatic solid tumors. This is an advanced treatment for metastatic hormone-receptor positive breast cancer and castration-resistant prostate cancer.
For the purpose of this report, Emergen Research has segmented the global peptide therapeutics market on the basis of type, application, route of administrations, type of manufacturers, distribution channel, and region:
Type Outlook (Revenue, USD Billion; 2019-2032)
Innovative
Generic
Application Outlook (Revenue, USD Billion; 2019-2032)
Metabolic Disorder
Respiratory Disorders
Cancer
Cardiovascular
Immunological
Neurological Disorders
Gastrointestinal (GI) Disorders
Renal Disorders
Others
Route of Administration Outlook (Revenue, USD Billion; 2019-2032)
Parenteral Route
Pulmonary
Oral Route
Mucosal
Others
Type of manufacturers Outlook (Revenue, USD Billion; 2019-2032)
In-house
Outsourced
Distribution Channel Outlook (Revenue, USD Billion; 2019-2032)
Hospital Pharmacies
Drug Store and Retail Pharmacies
Online Pharmacies
Regional Outlook (Revenue, USD Billion; 2019-2032)
North America
U.S.
Canada
Europe
Germany
France
UK
Italy
Spain
Benelux
Russia
Rest of Europe
Asia Pacific
China
Japan
South Korea
India
ASEAN Countries
Oceania
Rest of APAC
Latin America
Brazil
Mexico
Rest of LATAM
Middle East & Africa
GCC Countries
Israel
Turkey
South Africa
Rest of Middle East & Africa
Buy the full research report at @ https://www.emergenresearch.com/select-license/2736
Look Over transcripts provided by Emergen Research
Peptide Therapeutics Market Size@ https://www.emergenresearch.com/industry-report/peptide-therapeutics-market/market-size
Peptide Therapeutics Market Share@ https://www.emergenresearch.com/industry-report/peptide-therapeutics-market/market-share
Peptide Therapeutics Market Trends@ https://www.emergenresearch.com/industry-report/peptide-therapeutics-market/market-trends
Peptide Therapeutics Regional Market Demand@ https://www.emergenresearch.com/industry-report/peptide-therapeutics-market/regional-market-demand
Peptide Therapeutics Market Analysis@ https://www.emergenresearch.com/industry-report/peptide-therapeutics-market/market-analysis
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Peptide Therapeutics Market Poised for Significant Growth with Rising Cancer Prevalence and Technological Advancements here
News-ID: 3687129 • Views: …
More Releases from Emergen Research
Global Internet of Things (IoT) in Healthcare Market to Reach USD 299.05 Billion …
The global Internet of Things (IoT) in Healthcare Market was valued at USD 299.05 billion in 2023 and is expected to grow at a CAGR of 16.5% during the forecast period. This growth is fueled by the rising use of connected healthcare devices, increasing demand for early disease detection through remote monitoring, and growing adoption of artificial intelligence (AI) tools within IoT-based healthcare systems.
The market is also benefiting from the…
Global Stem Cell Therapy Market to Reach USD 49.2 Billion by 2034, Growing at 13 …
The global Stem Cell Therapy Market, valued at USD 13.7 billion in 2024, is projected to reach USD 49.2 billion by 2034, expanding at a compound annual growth rate (CAGR) of 13.6%. Growth is being fueled by the rising burden of chronic diseases, rapid progress in cell-based studies, and increasing investments in regenerative medicine and personalized healthcare solutions.
Stem cell therapies offer the ability to repair, replace, or restore damaged tissues…
Artificial Intelligence Strengthens Cybersecurity as Threats Grow More Sophistic …
The global Artificial Intelligence in cybersecurity market size was USD 23.8 Billion in 2023 and is expected to reach a market valuation of USD 29.44 billion by the end of 2024 registering a CAGR of 23.7% during the forecast period. The adoption of Artificial Intelligence (AI) in cybersecurity is rapidly gaining traction as organizations worldwide face increasingly complex and frequent cyber threats. By combining advanced technologies such as Machine Learning…
Global Regenerative Medicine Market to Reach USD 125.6 Billion by 2034, Growing …
The global regenerative medicine market, valued at USD 34.2 billion in 2024, is set to grow to USD 125.6 billion by 2034, expanding at a compound annual growth rate (CAGR) of 13.9%. Growth is being fueled by rising approvals of advanced therapies, strong demand for personalized treatments in cancer and orthopedics, and expanding cell and gene therapy manufacturing across major markets such as North America, Europe, and Asia.
Once seen as…
More Releases for Peptide
Copper Peptide GHK-Cu Market: Empowering Beauty and Health Innovations with Adva …
The global copper peptide GHK-Cu market is poised for transformative growth as innovative cosmetic and pharmaceutical formulations increasingly incorporate these bioactive peptides to promote skin rejuvenation, wound healing, and overall wellness. Driven by technological advancements, growing consumer awareness of anti-aging solutions, and an expanding portfolio of product applications, the market is set to evolve rapidly in the coming years. This industry provides an in-depth analysis of market information, key growth…
Shaping the Cell Penetrating Peptide Market in 2025: Innovative Peptide Drug Dis …
How Big Is the Cell Penetrating Peptide Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, the market size for cell penetrating peptides has expanded swiftly. The market is projected to rise from a value of $1.87 billion in 2024 to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.6%. The historic period's growth can be credited to an amplified comprehension…
Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights:
• Global Peptide Cancer Drug Market Insight By Region & Indication
• Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion
• Approved Peptide Cancer Drugs: > 30 Drugs
• Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis
• Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase
• Insight On Peptide Cancer Drugs In Clinical Trials: >…
Growing Adoption of Synthetic Peptide Drugs Driving Peptide Therapeutics Market …
Peptide Therapeutics Market size was valued at USD 40.69 billion in 2019 and is poised to grow from USD 43.11 billion in 2023 to USD 68.4 billion by 2031, growing at a CAGR of 5.94% in the forecast period (2024-2031).
[https://www.skyquestt.com/report/peptide-therapeutics-market] size was valued at USD 43.11 billion in 2023 to USD 68.4 billion by 2031, growing at a CAGR of 5.94% in the forecast period (2024-2031). The increasing prevalence of…
Global Adjuvant Peptide Market Size,Share, Research and Forecast,2023-2028| Pept …
The global Adjuvant Peptide market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Adjuvant Peptide market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global…
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established…
